Summary report on the graded prognostic assessment: an accurate and facile diagnosis-specific tool to estimate survival for patients with brain metastases

Classification and Regression Trees.

Gordon, A. D., Breiman, L., Friedman, J. H., Olshen, R. A., & Stone, C. J. (1984) · Biometrics · doi:10.2307/2530946 · Cited by 23,834 · see citing works

Classification and Regression Trees.

Ryzin, J. V., Breiman, L., Friedman, J. H., Olshen, R. A., & Stone, C. J. (1986) · Journal of the American Statistical Association · doi:10.2307/2288003 · Cited by 21,028 · see citing works

Cancer Statistics, 2008

Jemal, A., Siegel, R. L., Ward, E., Hao, Y., Xu, J., Murray, T., & Thun, M. J. (2008) · CA A Cancer Journal for Clinicians · doi:10.3322/ca.2007.0010 · Cited by 10,184 · see citing works

Recursive partitioning analysis (RPA) of prognostic factors in three radiation therapy oncology group (RTOG) brain metastases trials

Gaspar, L. E., Scott, C., Rotman, M., Asbell, S. O., Phillips, T. L., Wasserman, T. H., McKenna, W. G., & Byhardt, R. W. (1997) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(96)00619-0 · Cited by 2,548 · see citing works

A New Prognostic Index and Comparison to Three Other Indices for Patients With Brain Metastases: An Analysis of 1,960 Patients in the RTOG Database

Sperduto, P. W., Berkey, B. A., Gaspar, L. E., Mehta, M. P., & Curran, W. J. (2007) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2007.06.074 · Cited by 1,031 · see citing works

An Introduction to Recursive Partitioning Using the RPART Routines

Therneau, T. M., & Atkinson, E. J. (2015) · Cited by 1,006 · see citing works

Diagnosis-Specific Prognostic Factors, Indexes, and Treatment Outcomes for Patients With Newly Diagnosed Brain Metastases: A Multi-Institutional Analysis of 4,259 Patients

Sperduto, P. W., Chao, S. T., Sneed, P. K., Luo, X., Suh, J. H., Roberge, D., Bhatt, A. K., Jensen, A. W., Brown, P. D., Shih, H. A., et al. (2009) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2009.08.025 · Cited by 987 · see citing works

Intracerebral metastases in solid-tumor patients: Natural history and results of treatment

Zimm, S., Wampler, G. L., Stablein, D., Hazra, T. A., & Young, H. F. (1981) · Cancer · doi:10.1002/1097-0142(19810715)48:2 · Cited by 597 · see citing works

Validation of the RTOG recursive partitioning analysis (RPA) classification for brain metastases

Gaspar, L. E., Scott, C., Murray, K., & Curran, W. J. (2000) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(00)00547-2 · Cited by 531 · see citing works

Effect of Tumor Subtype on Survival and the Graded Prognostic Assessment for Patients With Breast Cancer and Brain Metastases

Sperduto, P. W., Kased, N., Roberge, D., Xu, Z., Shanley, R., Luo, X., Sneed, P. K., Chao, S. T., Weil, R. J., Suh, J. H., et al. (2011) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2011.02.027 · Cited by 367 · see citing works

Neurologic Complications of Cancer

Wen, P. Y., & Glantz, M. (2003) · Neurologic Clinics · doi:10.1016/s0733-8619(02)00100-7 · Cited by 362 · see citing works

A randomized phase III study of accelerated hyperfractionation versus standard in patients with unresected brain metastases: A report of the radiation therapy oncology group (RTOG) 9104

Murray, K. J., Scott, C., Greenberg, H., Emami, B., Seider, M. J., Vora, N. L., Olson, C., Whitton, A. C., Movsas, B., & Curran, W. J. (1997) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(97)00341-6 · Cited by 313 · see citing works

A randomized phase iii protocol for the evaluation of misonidazole combined with radiation in the treatment of patients with brain metastases (RTOG-7916)

Komarnicky, L. T., Phillips, T. L., Martz, K. L., Asbell, S. O., Isaacson, S. R., & Urtasun, R. C. (1991) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(91)90137-s · Cited by 235 · see citing works

Neurologic Complications of Cancer.

Sawaya, R. E., & Ligon, B. L. (1996) · Neurosurgery · doi:10.1227/00006123-199603000-00047 · Cited by 225 · see citing works

Results of a randomized comparison of radiotherapy and bromodeoxyuridine with radiotherapy alone for brain metastases: Report of RTOG trial 89-05

Phillips, T. L., Scott, C., Leibel, S. A., Rotman, M., & Weigensberg, I. J. (1995) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(95)00168-x · Cited by 185 · see citing works

A validation study of a new prognostic index for patients with brain metastases: the Graded Prognostic Assessment

Sperduto, C. M., Watanabe, Y., Mullan, J. C., Hood, T. W., Dyste, G. N., Watts, C. R., Bender, G. P., & Sperduto, P. W. (2008) · Journal of neurosurgery · doi:10.3171/jns/2008/109/12/s14 · Cited by 142 · see citing works

Phase I/II trial of accelerated fractionation in brain metastases RTOG 85-28

Sause, W. T., Scott, C., Krisch, R. E., Rotman, M., Sneed, P. K., Janjan, N. A., Davis, L. W., Curran, W. J., Choi, K. N., Selim, H., et al. (1993) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(93)90284-3 · Cited by 107 · see citing works

Survival of patients with nonseminomatous germ cell cancer: a review of the IGCC classification by Cox regression and recursive partitioning

van Dijk, M. R., Steyerberg, E. W., Stenning, S. P., Dusseldorp, E., & Habbema, J. D. F. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6601665 · Cited by 32 · see citing works

CHAUVINISM IN MEDICINE

Osler, W. (1979) · PEDIATRICS · doi:10.1542/peds.63.4.627 · Cited by 30 · see citing works

What Is Your Patient's GPA and Why Does It Matter? Managing Brain Metastases and the Cost of Hope

Sperduto, P. W. (2010) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2010.02.038 · Cited by 28 · see citing works

The effect of tumor subtype on survival and the graded prognostic assessment (GPA) for patients with breast cancer and brain metastases.

Sperduto, P. W., Kased, N., Roberge, D., Shanley, R., Chao, S. T., Bhatt, A. K., Brown, P. D. N., Shih, H.-S., Kirkpatrick, J. P., & Gaspar, L. E. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2011.29.27_suppl.238 · Cited by 7 · see citing works

Metastatic non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Novello, S., Barlesi, F., Califano, R., Cufer, T., Ekman, S., Levra, M. G., Kerr, K., Popat, S., Reck, M., Senan, S., et al. (2016) · Annals of Oncology · doi:10.1093/annonc/mdw326 · Cited by 2,631 · see citing works

Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2016 for the treatment of colorectal cancer

Japanese Society for Cancer of the Colon and Rectum, Watanabe, T., Muro, K., Ajioka, Y., Hashiguchi, Y., Ito, Y., Saito, Y., Hamaguchi, T., Ishida, H., Ishiguro, M., et al. (2018) · International Journal of Clinical Oncology · doi:10.1007/s10147-017-1101-6 · Cited by 2,467 · see citing works

Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Planchard, D., Popat, S., Kerr, K., Novello, S., Smit, E. F., Faivre-Finn, C., Mok, T. S., Reck, M., Van Schil, P. E., Hellmann, M. D., et al. (2018) · Annals of Oncology · doi:10.1093/annonc/mdy275 · Cited by 2,274 · see citing works

Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2019 for the treatment of colorectal cancer

Hashiguchi, Y., Muro, K., Saitō, Y., Ito, Y., Ajioka, Y., Hamaguchi, T., Hasegawa, K., Hotta, K., Ishida, H., Ishiguro, M., et al. (2019) · International Journal of Clinical Oncology · doi:10.1007/s10147-019-01485-z · Cited by 1,936 · see citing works

CNS Metastases in Breast Cancer: Old Challenge, New Frontiers

Lin, N., Amiri‐Kordestani, L., Palmieri, D., Liewehr, D. J., & Steeg, P. S. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-0790 · Cited by 1,290 · see citing works

Brain metastases

Achrol, A. S., Rennert, R. C., Anders, C. K., Soffietti, R., Ahluwalia, M. S., Nayak, L., Peters, S., Arvold, N. D., Harsh, G. R., Steeg, P. S., et al. (2019) · Nature Reviews Disease Primers · doi:10.1038/s41572-018-0055-y · Cited by 1,177 · see citing works

Metastatic non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Peters, S., Adjei, A. A., Gridelli, C., Reck, M., Kerr, K. M., & Felip, E. (2012) · Annals of Oncology · doi:10.1093/annonc/mds226 · Cited by 930 · see citing works

Hippocampal Avoidance During Whole-Brain Radiotherapy Plus Memantine for Patients With Brain Metastases: Phase III Trial NRG Oncology CC001

Brown, P. D., Gondi, V., Pugh, S. L., Tomé, W. A., Wefel, J. S., Armstrong, T. S., Bovi, J. A., Robinson, C. G., Konski, A. A., Khuntia, D., et al. (2020) · Journal of Clinical Oncology · doi:10.1200/jco.19.02767 · Cited by 862 · see citing works

Post-operative stereotactic radiosurgery versus observation for completely resected brain metastases: a single-centre, randomised, controlled, phase 3 trial

Mahajan, A., Ahmed, S., McAleer, M. F., Weinberg, J. S., Li, J., Brown, P. D., Settle, S. H., Prabhu, S. S., Lang, F. F., Levine, N. B., et al. (2017) · The Lancet Oncology · doi:10.1016/s1470-2045(17)30414-x · Cited by 801 · see citing works

Metastatic non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Reck, M., Popat, S., Reinmuth, N., Ruysscher, D. D., Kerr, K. M., & Peters, S. (2014) · Annals of Oncology · doi:10.1093/annonc/mdu199 · Cited by 679 · see citing works

Estimating Survival in Patients With Lung Cancer and Brain Metastases

Sperduto, P. W., Yang, J. T., Beal, K. P., Pan, H. Y., Brown, P. D., Bangdiwala, A. S., Shanley, R., Yeh, N., Gaspar, L. E., Braunstein, S. E., et al. (2016) · JAMA Oncology · doi:10.1001/jamaoncol.2016.3834 · Cited by 656 · see citing works

Pretreatment neutrophil-to-lymphocyte ratio as a marker of outcomes in nivolumab-treated patients with advanced non-small-cell lung cancer

Bagley, S. J., Kothari, S., Aggarwal, C., Bauml, J. M., Alley, E. W., Evans, T. L., Kosteva, J. A., Ciunci, C. A., Gabriel, P. E., Thompson, J. C., et al. (2017) · Lung Cancer · doi:10.1016/j.lungcan.2017.01.013 · Cited by 512 · see citing works

Single-Fraction Versus Multifraction (3 × 9 Gy) Stereotactic Radiosurgery for Large (>2 cm) Brain Metastases: A Comparative Analysis of Local Control and Risk of Radiation-Induced Brain Necrosis

Minniti, G. C., Scaringi, C., Paolini, S., Lanzetta, G., Romano, A., Cicone, F., Osti, M. F., Enrici, R. M., & Esposito, V. (2016) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2016.03.013 · Cited by 485 · see citing works

Survival in Patients With Brain Metastases: Summary Report on the Updated Diagnosis-Specific Graded Prognostic Assessment and Definition of the Eligibility Quotient

Sperduto, P. W., Mesko, S. M., Li, J., Cagney, D. N., Aizer, A. A., Lin, N., Nesbit, E. G., Kruser, T. J., Chan, J. W. S., Braunstein, S. E., et al. (2020) · Journal of Clinical Oncology · doi:10.1200/jco.20.01255 · Cited by 482 · see citing works

Nivolumab versus docetaxel in previously treated advanced non-small-cell lung cancer (CheckMate 017 and CheckMate 057): 3-year update and outcomes in patients with liver metastases

Vokes, E. E., Ready, N., Felip, E., Horn, L., Burgio, M. A., Antonia, S. J., Frontera, O. A., Gettinger, S. N., Holgado, E., Spigel, D. R., et al. (2018) · Annals of Oncology · doi:10.1093/annonc/mdy041 · Cited by 464 · see citing works

Management of Brain Metastases in Tyrosine Kinase Inhibitor–Naïve Epidermal Growth Factor Receptor–Mutant Non–Small-Cell Lung Cancer: A Retrospective Multi-Institutional Analysis

Magnuson, W. J., Lester-Coll, N. H., Wu, A. J.-C., Yang, J. T., Lockney, N. A., Gerber, N. K., Beal, K. P., Amini, A., Patil, T., Kavanagh, B. D., et al. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2016.69.7144 · Cited by 461 · see citing works

Treatment of Brain Metastases

Lin, X., & DeAngelis, L. M. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2015.60.9503 · Cited by 446 · see citing works

Appraisal of the Karnofsky Performance Status and proposal of a simple algorithmic system for its evaluation

Péus, D., Newcomb, N., & Höfer, S. (2013) · BMC Medical Informatics and Decision Making · doi:10.1186/1472-6947-13-72 · Cited by 437 · see citing works

Whole brain radiotherapy for the treatment of newly diagnosed multiple brain metastases

Tsao, M. N., Lloyd, N. S., Wong, R. K. S., Chow, E., Rakovitch, E., Laperrière, N., Xu, W., & Sahgal, A. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003869.pub3 · Cited by 434 · see citing works

Radiation Therapy for Brain Metastases: An ASTRO Clinical Practice Guideline

Gondi, V., Bauman, G. S., Bradfield, L., Burri, S. H., Cabrera, A. R., Cunningham, D. A., Eaton, B. R., Hattangadi-Gluth, J. A., Kim, M. M., Kotecha, R. R., et al. (2022) · Practical Radiation Oncology · doi:10.1016/j.prro.2022.02.003 · Cited by 417 · see citing works

Stereotactic Radiosurgery for Melanoma Brain Metastases in Patients Receiving Ipilimumab: Safety Profile and Efficacy of Combined Treatment

Kiess, A. P., Wolchok, J. D., Barker, C. A., Postow, M. A., Tabar, V. S., Huse, J. T., Chan, T. A.-T., Yamada, Y. J., & Beal, K. P. (2015) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2015.01.004 · Cited by 391 · see citing works

Recent trends in epidemiology of brain metastases: an overview.

Tabouret, É., Chinot, O. L., Métellus, P., Tallet, A. R., Viens, P., & Gonçalvès, A. (2012) · PubMed · Cited by 355 · see citing works

Long-term outcomes of patients with active melanoma brain metastases treated with combination nivolumab plus ipilimumab (CheckMate 204): final results of an open-label, multicentre, phase 2 study

Tawbi, H. A., Forsyth, P. A., Hodi, F. S., Algazi, A. P., Hamid, O., Lao, C. D., Moschos, S. J., Atkins, M. B., Lewis, K., Postow, M. A., et al. (2021) · The Lancet Oncology · doi:10.1016/s1470-2045(21)00545-3 · Cited by 350 · see citing works

Brain metastases: epidemiology

Ostrom, Q. T., Wright, C. H., & Barnholtz‐Sloan, J. S. (2018) · Handbook of clinical neurology · doi:10.1016/b978-0-12-811161-1.00002-5 · Cited by 334 · see citing works

Extended Survival and Prognostic Factors for Patients With ALK-Rearranged Non–Small-Cell Lung Cancer and Brain Metastasis

Johung, K. L., Yeh, N., Desai, N. B., Williams, T. M., Lautenschlaeger, T., Arvold, N. D., Ning, M. S., Attia, A. A., Lovly, C. M., Goldberg, S. B., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2015.62.0138 · Cited by 332 · see citing works

Brain Tumors

McFaline-Figueroa, J. R., & Lee, E. Q. (2018) · The American Journal of Medicine · doi:10.1016/j.amjmed.2017.12.039 · Cited by 299 · see citing works

Pan-Asian adapted Clinical Practice Guidelines for the management of patients with metastatic non-small-cell lung cancer: a CSCO–ESMO initiative endorsed by JSMO, KSMO, MOS, SSO and TOS

Wu, Y.-L., Planchard, D., Lü, S., Sun, H., Yamamoto, N., Kim, D., Tan, D. S.-W., Yang, J. C., Azrif, M., Mitsudomi, T., et al. (2018) · Annals of Oncology · doi:10.1093/annonc/mdy554 · Cited by 292 · see citing works

Epidemiology of Brain Metastases

Sacks, P., & Rahman, M. (2020) · Neurosurgery Clinics of North America · doi:10.1016/j.nec.2020.06.001 · Cited by 288 · see citing works

Radical treatment of non-small-cell lung cancer patients with synchronous oligometastases: long-term results of a prospective phase II trial (Nct01282450)

De Ruysscher, D., Wanders, R., van Baardwijk, A., Dingemans, A.-M. C., Reymen, B., Houben, R., Bootsma, G., Pitz, C., van Eijsden, L., Geraedts, W., et al. (2012) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e318262caf6 · Cited by 283 · see citing works

Updates in the management of brain metastases

Arvold, N. D., Lee, E. Q., Mehta, M. P., Margolin, K. A., Alexander, B. M., Lin, N., Anders, C. K., Soffietti, R., Camidge, D. R., Vogelbaum, M. A., et al. (2016) · Neuro-Oncology · doi:10.1093/neuonc/now127 · Cited by 276 · see citing works

A phase 3 trial of whole brain radiation therapy and stereotactic radiosurgery alone versus WBRT and SRS with temozolomide or erlotinib for non-small cell lung cancer and 1 to 3 brain metastases: Radiation Therapy Oncology Group 0320

Sperduto, P. W., Wang, M., Robins, H. I., Schell, M. C., Werner-Wasik, M., Komaki, R., Souhami, L., Buyyounouski, M. K., Khuntia, D., Demas, W., et al. (2013) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2012.11.042 · Cited by 274 · see citing works

Consensus recommendations for a standardized brain tumor imaging protocol for clinical trials in brain metastases

Kaufmann, T. J., Smits, M., Boxerman, J. L., Huang, R. Y., Barboriak, D. P., Weller, M., Chung, C. D., Tsien, C. I., Brown, P. D., Shankar, L. K., et al. (2020) · Neuro-Oncology · doi:10.1093/neuonc/noaa030 · Cited by 274 · see citing works

Treatment of brain metastases with stereotactic radiosurgery and immune checkpoint inhibitors: An international meta-analysis of individual patient data

Lehrer, E. J., Peterson, J., Brown, P. D., Sheehan, J. P., Quiñones‐Hinojosa, A., Zaorsky, N. G., & Trifiletti, D. M. (2018) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2018.08.025 · Cited by 267 · see citing works

Role of Radiation Therapy in Palliative Care of the Patient With Cancer

Lutz, S., Jones, J., & Chow, E. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2014.55.1143 · Cited by 266 · see citing works

Treatment strategies for breast cancer brain metastases

Bailleux, C., Eberst, L., & Bachelot, T. (2020) · British Journal of Cancer · doi:10.1038/s41416-020-01175-y · Cited by 239 · see citing works

Descriptive statistical analysis of a real life cohort of 2419 patients with brain metastases of solid cancers

Berghoff, A. S., Schur, S., Füreder, L. M., Gatterbauer, B., Dieckmann, K. U., Widhalm, G., Hainfellner, J. A., Zielinski, C. C., Birner, P., Bartsch, R., et al. (2016) · ESMO Open · doi:10.1136/esmoopen-2015-000024 · Cited by 237 · see citing works

Mechanisms of enhanced drug delivery in brain metastases with focused ultrasound-induced blood–tumor barrier disruption

Arvanitis, C., Askoxylakis, V., Guo, Y., Datta, M., Kloepper, J., Ferraro, G. B., Bernabéu, M. O., Fukumura, D., McDannold, N. J., & Jain, R. K. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1807105115 · Cited by 235 · see citing works

Evaluation of First-line Radiosurgery vs Whole-Brain Radiotherapy for Small Cell Lung Cancer Brain Metastases

Rusthoven, C. G., Yamamoto, M., Bernhardt, D., Smith, D. E., Gao, D., Serizawa, T., Yomo, S., Aiyama, H., Higuchi, Y., Shuto, T., et al. (2020) · JAMA Oncology · doi:10.1001/jamaoncol.2020.1271 · Cited by 225 · see citing works

Stereotactic Radiosurgery With or Without Whole-Brain Radiotherapy for Brain Metastases

Aoyama, H., Tago, M., & Shirato, H. (2015) · JAMA Oncology · doi:10.1001/jamaoncol.2015.1145 · Cited by 219 · see citing works

Systemic therapy of brain metastases: non–small cell lung cancer, breast cancer, and melanoma

Chamberlain, M. C., Baik, C. S., Gadi, V. K., Bhatia, S., & Chow, L. Q. M. (2016) · Neuro-Oncology · doi:10.1093/neuonc/now197 · Cited by 219 · see citing works

CAR T cells for brain tumors: Lessons learned and road ahead

Akhavan, D., Alizadeh, D., Wang, D., Weist, M. R., Shepphird, J. K., & Brown, C. E. (2019) · Immunological Reviews · doi:10.1111/imr.12773 · Cited by 211 · see citing works

Estimating Survival in Melanoma Patients With Brain Metastases: An Update of the Graded Prognostic Assessment for Melanoma Using Molecular Markers (Melanoma-molGPA)

Sperduto, P. W., Jiang, W., Brown, P. D., Braunstein, S. E., Sneed, P. K., Wattson, D. A., Shih, H. A., Bangdiwala, A. S., Shanley, R., Lockney, N. A., et al. (2017) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2017.06.2454 · Cited by 210 · see citing works

Whole brain radiotherapy for the treatment of newly diagnosed multiple brain metastases

Tsao, M. N., Xu, W., Wong, R. K. S., Lloyd, N. S., Laperrière, N., Sahgal, A., Rakovitch, E., & Chow, E. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003869.pub4 · Cited by 207 · see citing works

A Phase II Study of Abemaciclib in Patients with Brain Metastases Secondary to Hormone Receptor–Positive Breast Cancer

Tolaney, S. M., Sahebjam, S., Rhun, É. L., Bachelot, T., Kabos, P., Awada, A. H., Yardley, D. A., Chan, A., Conte, P., Dieras, V. C., et al. (2020) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-20-1764 · Cited by 203 · see citing works

Stereotactic radiosurgery for treatment of brain metastases

Köcher, M., Wittig, A., Piroth, M. D., Treuer, H., Seegenschmiedt, H. M., Ruge, M. I., Grosu, A., & Gückenberger, M. (2014) · Strahlentherapie und Onkologie · doi:10.1007/s00066-014-0648-7 · Cited by 197 · see citing works

Tumor volume as a predictor of survival and local control in patients with brain metastases treated with Gamma Knife surgery

Baschnagel, A. M., Meyer, K., Chen, P. Y., Krauss, D. J., Olson, R. E., Pieper, D. R., Maitz, A. H., Ye, H., & Grills, I. S. (2013) · Journal of neurosurgery · doi:10.3171/2013.7.jns13431 · Cited by 196 · see citing works

Fractionated stereotactic radiosurgery for patients with brain metastases

Minniti, G. C., D’Angelillo, R. M., Scaringi, C., Trodella, L. E., Clarke, E., Matteucci, P., Osti, M. F., Ramella, S., Enrici, R. M., & Trodella, L. (2014) · Journal of Neuro-Oncology · doi:10.1007/s11060-014-1388-3 · Cited by 189 · see citing works

Safety and efficacy of pralsetinib in RET fusion–positive non-small-cell lung cancer including as first-line therapy: update from the ARROW trial

Griesinger, F., Curigliano, G., Thomas, M., Subbiah, V., Baik, C. S., Tan, D. S. W., Lee, D., Misch, D., Garralda, E., Kim, D.-W., et al. (2022) · Annals of Oncology · doi:10.1016/j.annonc.2022.08.002 · Cited by 186 · see citing works

Extracranial Oligometastases: A Subset of Metastases Curable With Stereotactic Radiotherapy

Corbin, K. S., Hellmän, S., & Weichselbaum, R. R. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.45.9651 · Cited by 185 · see citing works

Treatment outcomes and prognostic factors for patients with brain metastases from breast cancer of each subtype: a multicenter retrospective analysis

Niikura, N., Hayashi, N., Masuda, N., Takashima, S., Nakamura, R., Watanabe, K., Kanbayashi, C., Ishida, M., Hozumi, Y., Tsuneizumi, M., et al. (2014) · Breast Cancer Research and Treatment · doi:10.1007/s10549-014-3090-8 · Cited by 182 · see citing works

Icotinib versus whole-brain irradiation in patients with EGFR -mutant non-small-cell lung cancer and multiple brain metastases (BRAIN): a multicentre, phase 3, open-label, parallel, randomised controlled trial

Yang, J., Zhou, C., Huang, Y.-S., Feng, J., Sun, L., Song, Y., Huang, C., Wu, G., Zhang, L., Cheng, Y., et al. (2017) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(17)30262-x · Cited by 181 · see citing works

Secondary Analysis of RTOG 9508, a Phase 3 Randomized Trial of Whole-Brain Radiation Therapy Versus WBRT Plus Stereotactic Radiosurgery in Patients With 1-3 Brain Metastases; Poststratified by the Graded Prognostic Assessment (GPA)

Sperduto, P. W., Shanley, R., Luo, X., Andrews, D. W., Werner‐Wasik, M., Valicenti, R. K., Bahary, J.-P., Souhami, L., Won, M., & Mehta, M. P. (2014) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2014.07.002 · Cited by 174 · see citing works

Management of brain metastases according to molecular subtypes

Soffietti, R., Ahluwalia, M. S., Lin, N., & Rudà, R. (2020) · Nature Reviews Neurology · doi:10.1038/s41582-020-0391-x · Cited by 174 · see citing works

Translational Breast Cancer Research Consortium (TBCRC) 022: A Phase II Trial of Neratinib for Patients With Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer and Brain Metastases

Freedman, R. A., Gelman, R. S., Wefel, J. S., Melisko, M., Hess, K. R., Connolly, R. M., Poznak, C. H. V., Niravath, P. A., Puhalla, S. L., Ibrahim, N. K., et al. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2015.63.0343 · Cited by 172 · see citing works

Defining the Optimal Planning Target Volume in Image-Guided Stereotactic Radiosurgery of Brain Metastases: Results of a Randomized Trial

Kirkpatrick, J. P., Wang, Z., Sampson, J. H., McSherry, F., Herndon, J. E., Allen, K. J., Duffy, E. A., Hoang, J. K., Chang, Z., Yoo, D. S., et al. (2014) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2014.09.004 · Cited by 171 · see citing works

Association Between Radiation Necrosis and Tumor Biology After Stereotactic Radiosurgery for Brain Metastasis

Miller, J. A., Bennett, E., Xiao, R., Kotecha, R. R., Chao, S. T., Vogelbaum, M. A., Barnett, G. H., Angelov, L., Murphy, E. S., Yu, J. S., et al. (2016) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2016.08.039 · Cited by 169 · see citing works

Molecular and cellular mechanisms underlying brain metastasis of breast cancer

Hosonaga, M., Saya, H., & Arima, Y. (2020) · Cancer and Metastasis Reviews · doi:10.1007/s10555-020-09881-y · Cited by 162 · see citing works

The effect of tumor subtype on the time from primary diagnosis to development of brain metastases and survival in patients with breast cancer

Sperduto, P. W., Kased, N., Roberge, D., Chao, S. T., Shanley, R., Luo, X., Sneed, P. K., Suh, J. H., Weil, R. J., Jensen, A. W., et al. (2013) · Journal of Neuro-Oncology · doi:10.1007/s11060-013-1083-9 · Cited by 160 · see citing works

Stereotactic radiosurgery (SRS) in the modern management of patients with brain metastases

Soliman, H., Das, S., Larson, D. A., & Sahgal, A. (2016) · Oncotarget · doi:10.18632/oncotarget.7131 · Cited by 157 · see citing works

Initial SRS for Patients With 5 to 15 Brain Metastases: Results of a Multi-Institutional Experience

Hughes, R. T., Masters, A. H., McTyre, E., Farris, M. K., Chung, C. D., Page, B. R., Kleinberg, L. R., Hepel, J. T., Contessa, J. N., Chiang, V., et al. (2019) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2019.03.052 · Cited by 153 · see citing works

Indications and limitations of chemotherapy and targeted agents in non-small cell lung cancer brain metastases

Zimmermann, S., Dziadziuszko, R., & Peters, S. (2014) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2014.03.005 · Cited by 147 · see citing works

Emerging Strategies for Treating Brain Metastases from Breast Cancer

Kodack, D. P., Askoxylakis, V., Ferraro, G. B., Fukumura, D., & Jain, R. K. (2015) · Cancer Cell · doi:10.1016/j.ccell.2015.01.001 · Cited by 147 · see citing works

AGO Recommendations for Diagnosis and Treatment of Patients with Advanced and Metastatic Breast Cancer: Update 2013

Harbeck, N., Scharl, A. J., Thomssen, C., & Müller, V. (2013) · Breast Care · doi:10.1159/000353590 · Cited by 146 · see citing works

Beyond an Updated Graded Prognostic Assessment (Breast GPA): A Prognostic Index and Trends in Treatment and Survival in Breast Cancer Brain Metastases From 1985 to Today

Sperduto, P. W., Mesko, S. M., Li, J., Cagney, D. N., Aizer, A. A., Lin, N., Nesbit, E. G., Kruser, T. J., Chan, J. W. S., Braunstein, S. E., et al. (2020) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2020.01.051 · Cited by 146 · see citing works

Challenges relating to solid tumour brain metastases in clinical trials, part 2: neurocognitive, neurological, and quality-of-life outcomes. A report from the RANO group

Lin, N., Wefel, J. S., Lee, E. Q., Schiff, D., van den Bent, M. J., Soffietti, R., Suh, J. H., Vogelbaum, M. A., Mehta, M. P., Dancey, J. E., et al. (2013) · The Lancet Oncology · doi:10.1016/s1470-2045(13)70308-5 · Cited by 142 · see citing works

EGFR TKIs plus WBRT Demonstrated No Survival Benefit Other Than That of TKIs Alone in Patients with NSCLC and EGFR Mutation and Brain Metastases

Jiang, T., Su, C., Li, X., Zhao, C., Zhou, F., Ren, S., Zhou, C., & Zhang, J. (2016) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2016.05.013 · Cited by 140 · see citing works

Intrathecal administration of trastuzumab for the treatment of meningeal carcinomatosis in HER2-positive metastatic breast cancer: a systematic review and pooled analysis

Zagouri, F., Sergentanis, T. Ν., Bartsch, R., Berghoff, A. S., Chrysikos, D., de Azambuja, E., Dimopoulos, M. A., & Preusser, M. (2013) · Breast Cancer Research and Treatment · doi:10.1007/s10549-013-2525-y · Cited by 133 · see citing works

Intracranial response to nivolumab in NSCLC patients with untreated or progressing CNS metastases

Dudnik, E., Yust‐Katz, S., Nechushtan, H., Goldstein, D. A., Zer, A., Flex, D., Siegal, T., & Peled, N. (2016) · Lung Cancer · doi:10.1016/j.lungcan.2016.05.031 · Cited by 133 · see citing works

Graded Prognostic Assessment (GPA) for Patients With Lung Cancer and Brain Metastases: Initial Report of the Small Cell Lung Cancer GPA and Update of the Non-Small Cell Lung Cancer GPA Including the Effect of Programmed Death Ligand 1 and Other Prognostic Factors

Sperduto, P. W., De, B. S., Li, J., Carpenter, D. J., Kirkpatrick, J. P., Milligan, M., Shih, H. A., Kütük, T., Kotecha, R. R., Higaki, H., et al. (2022) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2022.03.020 · Cited by 131 · see citing works

Tumor infiltrating lymphocytes and PD-L1 expression in brain metastases of small cell lung cancer (SCLC)

Berghoff, A. S., Ricken, G., Wilhelm, D., Rajky, O., Widhalm, G., Dieckmann, K. U., Birner, P., Bartsch, R., & Preusser, M. (2016) · Journal of Neuro-Oncology · doi:10.1007/s11060-016-2216-8 · Cited by 130 · see citing works

Challenges relating to solid tumour brain metastases in clinical trials, part 1: patient population, response, and progression. A report from the RANO group

Lin, N., Lee, E. Q., Aoyama, H., Barani, I. J., Baumert, B. G., Brown, P. D., Camidge, D. R., Chang, S. M., Dancey, J. E., Gaspar, L. E., et al. (2013) · The Lancet Oncology · doi:10.1016/s1470-2045(13)70311-5 · Cited by 128 · see citing works

Modernizing Clinical Trial Eligibility Criteria: Recommendations of the American Society of Clinical Oncology–Friends of Cancer Research Brain Metastases Working Group

Lin, N., Prowell, T. M., Tan, A. R., Kozak, M., Rosen, O., Amiri‐Kordestani, L., White, J. R., Sul, J., Perkins, L. M., Beal, K., et al. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2017.74.0761 · Cited by 128 · see citing works

Neurocognitive assessment following whole brain radiation therapy and radiosurgery for patients with cerebral metastases: Table 1

McDuff, S. G. R., Taich, Z. J., Lawson, J. D., Sanghvi, P. R., Wong, E. T., Barker, F. G., Hochberg, F. H., Loeffler, J. S., Warnke, P. C., Murphy, K. T., et al. (2013) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2013-305166 · Cited by 127 · see citing works

Outcomes targeting the PD-1/PD-L1 axis in conjunction with stereotactic radiation for patients with non-small cell lung cancer brain metastases

Ahmed, K. A., Kim, S., Arrington, J. A., Naghavi, A. O., Dilling, T. J., Creelan, B., Antonia, S. J., Caudell, J. J., Harrison, L. B., Sahebjam, S., et al. (2017) · Journal of Neuro-Oncology · doi:10.1007/s11060-017-2437-5 · Cited by 126 · see citing works

Distribution and prognostic relevance of tumor-infiltrating lymphocytes (TILs) and PD-1/PD-L1 immune checkpoints in human brain metastases

Harter, P. N., Bernatz, S., Scholz, A., Zeiner, P. S., Zinke, J., Kiyose, M., Blasel, S., Beschorner, R., Senft, C., Bender, B., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.5696 · Cited by 125 · see citing works

Stereotactic radiosurgery combined with nivolumab or Ipilimumab for patients with melanoma brain metastases: evaluation of brain control and toxicity

Minniti, G. C., Anzellini, D., Reverberi, C., Cappellini, G. C. A., Marchetti, L., Bianciardi, F., Bozzao, A., Osti, M. F., Gentile, P. C., & Esposito, V. (2019) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-019-0588-y · Cited by 123 · see citing works

Survival prediction using temporal muscle thickness measurements on cranial magnetic resonance images in patients with newly diagnosed brain metastases

Furtner, J., Berghoff, A. S., Albtoush, O. M., Woitek, R., Asenbaum, U., Prayer, D., Widhalm, G., Gatterbauer, B., Dieckmann, K. U., Birner, P., et al. (2017) · European Radiology · doi:10.1007/s00330-016-4707-6 · Cited by 122 · see citing works

Validation and Development of a Modified Breast Graded Prognostic Assessment As a Tool for Survival in Patients With Breast Cancer and Brain Metastases

Subbiah, I. M., Lei, X. J., Weinberg, J. S., Sulman, E. P., Chávez‐MacGregor, M., Tripathy, D., Gupta, R., Varma, A., Chouhan, J. S., Guevarra, R. P., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.58.8517 · Cited by 119 · see citing works

Melanoma brain metastases treated with stereotactic radiosurgery and concurrent pembrolizumab display marked regression; efficacy and safety of combined treatment

Anderson, E. S., Postow, M. A., Wolchok, J. D., Young, R. J., Ballangrud, Å., Chan, T. A.-T., Yamada, Y. J., & Beal, K. P. (2017) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-017-0282-x · Cited by 118 · see citing works

Systemic treatment of brain metastases in non-small cell lung cancer

Page, S., Milner-Watts, C., Perna, M., Janžič, U., Vidal, N., Kaudeer, N., Ahmed, M., McDonald, F., Locke, I., Minchom, A. R., et al. (2020) · European Journal of Cancer · doi:10.1016/j.ejca.2020.03.006 · Cited by 118 · see citing works

Impact of 2-staged stereotactic radiosurgery for treatment of brain metastases ≥ 2 cm

Angelov, L., Mohammadi, A. M., Bennett, E., Abbassy, M. A., Elson, P. J., Chao, S. T., Montgomery, J. S., Habboub, G., Vogelbaum, M. A., Suh, J. H., et al. (2017) · Journal of neurosurgery · doi:10.3171/2017.3.jns162532 · Cited by 117 · see citing works

Subtype switching in breast cancer brain metastases: a multicenter analysis

Hulsbergen, A. F. C., Claes, A., Kavouridis, V. K., Ansaripour, A., Nogarede, C. O., Hughes, M. E., Smith, T. R., Brastianos, P. K., Verhoeff, J. J. C., Lin, N., et al. (2020) · Neuro-Oncology · doi:10.1093/neuonc/noaa013 · Cited by 116 · see citing works

Karnofsky performance status before and after liver transplantation predicts graft and patient survival

Thuluvath, P. J., Thuluvath, A. J., & Savva, Y. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.05.025 · Cited by 115 · see citing works

EGFR tyrosine kinase inhibitors versus cranial radiation therapy for EGFR mutant non-small cell lung cancer with brain metastases: a systematic review and meta-analysis

Soon, Y. Y., Leong, C. N., Koh, W. Y., & Tham, I. W. K. (2015) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2014.12.011 · Cited by 110 · see citing works

Tumour‐infiltrating lymphocytes and expression of programmed death ligand 1 (PD‐L1) in melanoma brain metastases

Berghoff, A. S., Ricken, G., Widhalm, G., Rajky, O., Dieckmann, K. U., Birner, P., Bartsch, R., Höeller, C., & Preusser, M. (2014) · Histopathology · doi:10.1111/his.12537 · Cited by 110 · see citing works

Neurocognitive functioning and health-related quality of life in patients treated with stereotactic radiotherapy for brain metastases: a prospective study

Habets, E. J. J., Dirven, L., Wiggenraad, R. G. J., Kanter, A. V.-D., Nijeholt, G. J. L. À., Zwinkels, H., Klein, M., & TAPHOORN, M. J. B. (2015) · Neuro-Oncology · doi:10.1093/neuonc/nov186 · Cited by 110 · see citing works

Prophylactic cranial irradiation for patients with lung cancer

Pechoux, C. L., Sun, A. Y., Slotman, B. J., Ruysscher, D. D., Belderbos, J. S. A., & Gore, E. (2016) · The Lancet Oncology · doi:10.1016/s1470-2045(16)30065-1 · Cited by 110 · see citing works

Congress of Neurological Surgeons Systematic Review and Evidence-Based Guidelines on the Use of Stereotactic Radiosurgery in the Treatment of Adults With Metastatic Brain Tumors

Graber, J. J., Cobbs, C., & Olson, J. J. (2018) · Neurosurgery · doi:10.1093/neuros/nyy543 · Cited by 108 · see citing works

The radiomic-clinical model using the SHAP method for assessing the treatment response of whole-brain radiotherapy: a multicentric study

Wang, Y., Lang, J., Zuo, J. Z., Dong, Y., Hu, Z., Xu, X., Zhang, Y., Wang, Q., Yang, L., Wong, S. T. C., et al. (2022) · European Radiology · doi:10.1007/s00330-022-08887-0 · Cited by 108 · see citing works

Postoperative Stereotactic Radiosurgery Without Whole-Brain Radiation Therapy for Brain Metastases: Potential Role of Preoperative Tumor Size

Hartford, A. C., Paravati, A. J., Spire, W. J., Li, Z., Jarvis, L. A., Fadul, C. E., Rhodes, C. H., Erkmen, K., Friedman, J. M., Gladstone, D. J., et al. (2012) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2012.05.027 · Cited by 107 · see citing works

Molecular subtype predicts incidence and prognosis of brain metastasis from breast cancer in SEER database

Kim, Y., Js, K., & Kim, I. A. (2018) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-018-2697-2 · Cited by 107 · see citing works

Palliative radiotherapy at the end of life: A critical review

Jones, J., Lutz, S., Chow, E., & Johnstone, P. A. S. (2014) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.21242 · Cited by 106 · see citing works

Intracerebral efficacy and tolerance of nivolumab in non–small-cell lung cancer patients with brain metastases

Gauvain, C., Vauléon, E., CHOUAID, C., Rhun, É. L., Jabot, L., Scherpereel, A., Vinas, F., Cortot, A. B., & Monnet, I. (2017) · Lung Cancer · doi:10.1016/j.lungcan.2017.12.008 · Cited by 104 · see citing works

Effectiveness and safety of nivolumab in advanced non-small cell lung cancer: The real-life data

Dudnik, E., Moskovitz, M. T., Daher, S., Shamai, S., Hanovich, E., Grubstein, A., Shochat, T., Wollner, M., Bar, J., Merimsky, O., et al. (2017) · Lung Cancer · doi:10.1016/j.lungcan.2017.11.015 · Cited by 103 · see citing works

Evolving treatment options for melanoma brain metastases

Ajithkumar, T., Parkinson, C., Fife, K. M., Corrie, P. G., & Jefferies, S. (2015) · The Lancet Oncology · doi:10.1016/s1470-2045(15)00141-2 · Cited by 102 · see citing works

Targeting brain metastases in breast cancer

Corti, C., Antonarelli, G., Criscitiello, C., Lin, N., Carey, L., Cortés, J., Poortmans, P. M., & Curigliano, G. (2021) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2021.102324 · Cited by 100 · see citing works

Impact of Deferring Radiation Therapy in Patients With Epidermal Growth Factor Receptor–Mutant Non-Small Cell Lung Cancer Who Develop Brain Metastases

Magnuson, W. J., Yeung, J. T., Guillod, P., Gettinger, S. N., Yu, J. B., & Chiang, V. (2016) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2016.01.037 · Cited by 99 · see citing works

Insights into brain metastasis in patients with ALK+ lung cancer: is the brain truly a sanctuary?

Toyokawa, G., Seto, T., Takenoyama, M., & Ichinose, Y. (2015) · Cancer and Metastasis Reviews · doi:10.1007/s10555-015-9592-y · Cited by 99 · see citing works

Correlation between EGFR mutation status and the incidence of brain metastases in patients with non-small cell lung cancer

Li, L., Luo, S., Lin, H., Yang, H., Chen, H., Liao, Z., Lin, W., Zheng, W., & Xie, X. (2017) · Journal of Thoracic Disease · doi:10.21037/jtd.2017.07.57 · Cited by 97 · see citing works

Erlotinib versus radiation therapy for brain metastases in patients with EGFR-mutant lung adenocarcinoma

Gerber, N. K., Yamada, Y., Rimner, A., Shi, W., Riely, G. J., Beal, K., Yu, H. A., Chan, T. A., Zhang, Z., & Wu, A. J. (2014) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2014.02.022 · Cited by 96 · see citing works

Diagnosis-Specific Prognostic Factors, Indexes, and Treatment Outcomes for Patients With Newly Diagnosed Brain Metastases: A Multi-Institutional Analysis of 4,259 Patients

Sperduto, P. W., Chao, S. T., Sneed, P. K., Luo, X., Suh, J. H., Roberge, D., Bhatt, A. K., Jensen, A. W., Brown, P. D., Shih, H. A., et al. (2009) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2009.08.025 · Cited by 987 · see citing works

Application of Prognostic Index Graded Prognostic Assessment(GPA) in Lung Cancer with Brain Metastases

Hai-guan, T. (2014) · Journal of Chinese Oncology · Cited by 1 · see citing works

A validation study of a new prognostic index for patients with brain metastases: the Graded Prognostic Assessment

Sperduto, C. M., Watanabe, Y., Mullan, J. C., Hood, T. W., Dyste, G. N., Watts, C. R., Bender, G. P., & Sperduto, P. W. (2008) · Journal of neurosurgery · doi:10.3171/jns/2008/109/12/s14 · Cited by 142 · see citing works

A validation study of graded prognostic assessment index for lung cancer patients with brain metastases.

Du, L., Venur, V. A., Dahiya, S., Garje, R., Osei-Boateng, K., Elson, P. J., Suh, J. H., Chao, S. T., & Ahluwalia, M. S. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2013.31.15_suppl.2070 · Cited by 1 · see citing works

Application of New Prognostic Index GPA in Lung Cancer with Brain Metastases

Yao-xiong, X. (2012) · Kunming Yike Daxue xuebao